RegisterLogin

NaPi2b Inhibitor 15

CAT: 0931-T70605-01Size: 25 mgDry Ice: NoHazardous: No
CAT#: T70605-01Size: 25 mg
Selected
PRICE
AVAILABILITY
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
CAS Number
1453116-06-7
Target
Others|||Sodium Channel
Related Pathways
Others|||Membrane transporter/Ion channel
Bioactivity
NaPi2b is primarily expressed in the small intestine, lungs, and testes and plays an important role in phosphate homeostasis. The inhibition of NaPi2b, responsible for intestinal phosphate absorption, is considered to reduce serum phosphate levels, making it a promising therapeutic approach for hyperphosphatemia
Smiles
C(N/N=C/C1=CC(C(F)(F)F)=C(Cl)C=C1)(=O)C=2C3=C(SC2NC(=O)C4=CC(COCCOCCOCCOCCOCCOCCN(CCOC)CC(O)=O)=CC=C4)CC(C)(C)CC3
Molecular Formula
C44H58ClF3N4O11S
Molecular Weight
943.46
Shipping Conditions
Cool pack
Storage Temperature
-20°C

Related Products

CatalogName
T78146-01NaPi2b-IN-2
T62737-01KRAS inhibitor-15
T205729-01FGFR1 inhibitor-15
T203503-01WRN inhibitor 15
T61327-01BRD4 Inhibitor-15
T61612-01ATX inhibitor 15
T60459-01Tubulin inhibitor 15
T61797-01HIV-1 inhibitor-15
T205379-01Protein kinase inhibitor 15
T11769-01KRAS G12C inhibitor 15

Alternative Products

CatalogName
MBS5813144NaPi2b Inhibitor 15
HY-145894-01NaPi2b-IN-2
MBS5819815NaPi2b-IN-2
052867NaPi2b (SLC34A2)
HY-146429NaPi2b-IN-3
HY-142957NaPi2b-IN-1
E55A06616Human SLC34A2/NaPi2b Antibody
E55A01811SLC34A2/ NaPi2b Polyclonal Antibody
048221NaPi2b/SLC34A2 (Lifastuzumab) discontinued
C37B-01Recombinant Human NaPi2b (VLP)

Popular Products